The New England journal of medicine, 2023-02, Vol.388 (7), p.595-608
2023
Details
- Autor(en) / Beteiligte
- Titel
- Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
- Ist Teil von
- The New England journal of medicine, 2023-02, Vol.388 (7), p.595-608
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2023
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Respiratory syncytial virus causes clinically significant illness in children and adults. In a placebo-controlled trial, a prefusion stabilized F protein vaccine led to an 83% lower risk of RSV infection.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2209604Titel-ID: cdi_proquest_miscellaneous_2777402719
- Format
- –
- Schlagworte
- Adjuvants, Immunologic - administration & dosage, Adjuvants, Immunologic - adverse effects, Adjuvants, Immunologic - therapeutic use, Adverse events, Age, Aged, Aging, Aging General, Antibodies, Viral, Coronaviruses, COVID-19, Demographic aspects, Disease, F protein, Geriatrics, Global Health, Health aspects, Humans, Immunization, Infections, Infectious Disease, Infectious Disease General, Internationality, Older people, Placebos, Polymerase chain reaction, Prevention, Proteins, Respiratory syncytial virus, Respiratory Syncytial Virus Infections - epidemiology, Respiratory Syncytial Virus Infections - prevention & control, Respiratory Syncytial Virus Vaccines - administration & dosage, Respiratory Syncytial Virus Vaccines - adverse effects, Respiratory Syncytial Virus Vaccines - therapeutic use, Respiratory Syncytial Virus, Human, Respiratory tract diseases, Respiratory tract infections, Respiratory Tract Infections - epidemiology, Respiratory Tract Infections - prevention & control, Risk factors, Seasons, Vaccine Efficacy, Vaccines, Viral Infections